Lenalidomide for Refractory Cutaneous Manifestations of Pediatric Systemic Lupus Erythematosus

    November 2016 in “ Lupus
    Eveline Y. Wu, Laura E. Schanberg, E C Wershba, C. Egla Rabinovich
    Studysummary In this retrospective study of adolescents with recalcitrant cutaneous lupus, lenalidomide treatment resulted in complete or near resolution of skin symptoms within 6 months, while allowing for a reduction in prednisone dosage.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’